The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin
Clinical trial registration, sponsored by Johns Hopkins University, registered 16 Oct 2026.
Phase 1 · not yet recruiting · n = 80
Tags: Registry, Psilocybin.
Newly registered at Johns Hopkins: psilocybin's impairing and abuse-related effects benchmarked against placebo and alcohol
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original
